Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
donald trump
6
×
fda
6
×
indiana blog main
indiana top stories
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
life sciences
regeneron pharmaceuticals
scott gottlieb
abeona therapeutics
bristol-myers squibb
medicare
novartis
pricing
affordable care act
agios pharmaceuticals
akcea therapeutics
alirocuma
What
roundup
bio
nash
american
based
best
continue
crash
debate
healthcare
industry
kind
people
pharmaceutical
policy
politicians
pressure
scalps
trump’s
u.s
according
afternoon
airport
akcea
allogene
annual
anticipated
apocalypse
awaited
beds
biotech
blueprint
cancer
cases
celgene
centers
cigarettes
control
cost
crispr
Language
unset
Current search:
fda
×
" donald trump "
×
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
6 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details
